Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Baseline serum calcium was significantly lower and any vitamin D treatment significantly higher in patients with a decrease in ΔiPTH.

Source: A decrease in ΔiPTH levels within 12 months is associated with increased mortality in the next 12 months. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were excluded if they did not consent, had positive serology for HBsAg, anti-HVC or anti-HIV or a life expectancy <6 months.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients

Study design awaiting verification · PLoS ONE · 2017

Original publication title

A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients

Ricardo Villa-Bellosta; Laura Rodriguez-Osorio; Sebastian Mas; Younes Abadi; Mercedes Rubert; Concepción de la Piedra; Carolina Gracia-Iguacel; Ignacio Mahillo; Alberto Ortiz; Jesús Egido; Emilio González-Parra

© 2017 Villa-Bellosta et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In prevalent hemodialysis patients with median baseline iPTH values within the guideline recommended range, a decrease in ΔiPTH was associated with higher mortality. Further studies are required to understand the mechanisms and therapeutic implications of this observation that challenges current clinical practice.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The mortality of dialysis patients is 10: to 100-fold higher than in the general population. Baseline serum PTH levels, and more recently, changes in serum PTH levels (ΔPTH) over time, have been associated to mortality in dialysis patients.

Source: Background

Abstract: What methods does the paper describe?

We explored the relationship between ΔPTH over 1 year with mortality over the next year in a prospective cohort of 115 prevalent hemodialysis patients from a single center that had median baseline iPTH levels within guideline recommendations.

Source: Methods

Abstract: Results

Median baseline iPTH levels were 205 (116.5, 400) pg/ml. ΔiPTH between baseline and 1 year was 85.2 ± 57.1 pg/ml. During the second year of follow-up, 27 patients died. ΔiPTH was significantly higher in patients who survived (+157.30 ± 25.82 pg/ml) than in those who died (+39.03 ± 60.95 pg/ml), while baseline iPTH values were not significantly different. The highest mortality (48%) was observed in patients with a decrease in ΔiPTH (ΔiPTH quartile 1, negative ΔiPTH) and the lowest (12%) mortality in quartile 3 ΔiPTH (ΔiPTH increase 101 to 300 pg/ml).

In a logistic regression model, ΔiPTH was associated with mortality with an odds ratio (OR) of 0.998 (95% CI 0.996 to 0999, p = 0.038). In multivariable analysis, mortality risk was 73% and 88% lower for patients with ΔiPTH 0 to 100 pg/ml and 101 to 300 pg/ml, respectively, than for those with a decrease in ΔiPTH. In patients with a decrease in ΔiPTH, the OR for death was 4.131 (1.515 to 11.27)(p = 0.006).

Source: Results

Abstract: Conclusions

In prevalent hemodialysis patients with median baseline iPTH values within the guideline recommended range, a decrease in ΔiPTH was associated with higher mortality. Further studies are required to understand the mechanisms and therapeutic implications of this observation that challenges current clinical practice.

Source: Conclusions
Authors’ abstract

Background

The mortality of dialysis patients is 10: to 100-fold higher than in the general population. Baseline serum PTH levels, and more recently, changes in serum PTH levels (ΔPTH) over time, have been associated to mortality in dialysis patients.

Methods

We explored the relationship between ΔPTH over 1 year with mortality over the next year in a prospective cohort of 115 prevalent hemodialysis patients from a single center that had median baseline iPTH levels within guideline recommendations.

Results

Median baseline iPTH levels were 205 (116.5, 400) pg/ml. ΔiPTH between baseline and 1 year was 85.2 ± 57.1 pg/ml. During the second year of follow-up, 27 patients died. ΔiPTH was significantly higher in patients who survived (+157.30 ± 25.82 pg/ml) than in those who died (+39.03 ± 60.95 pg/ml), while baseline iPTH values were not significantly different. The highest mortality (48%) was observed in patients with a decrease in ΔiPTH (ΔiPTH quartile 1, negative ΔiPTH) and the lowest (12%) mortality in quartile 3 ΔiPTH (ΔiPTH increase 101 to 300 pg/ml).

In a logistic regression model, ΔiPTH was associated with mortality with an odds ratio (OR) of 0.998 (95% CI 0.996 to 0999, p = 0.038). In multivariable analysis, mortality risk was 73% and 88% lower for patients with ΔiPTH 0 to 100 pg/ml and 101 to 300 pg/ml, respectively, than for those with a decrease in ΔiPTH. In patients with a decrease in ΔiPTH, the OR for death was 4.131 (1.515 to 11.27)(p = 0.006).

Conclusions

In prevalent hemodialysis patients with median baseline iPTH values within the guideline recommended range, a decrease in ΔiPTH was associated with higher mortality. Further studies are required to understand the mechanisms and therapeutic implications of this observation that challenges current clinical practice.

Publication and source details

Original title: A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients

Ricardo Villa-Bellosta; Laura Rodriguez-Osorio; Sebastian Mas; Younes Abadi; Mercedes Rubert; Concepción de la Piedra; Carolina Gracia-Iguacel; Ignacio Mahillo; Alberto Ortiz; Jesús Egido; Emilio González-Parra

PLoS ONE · 2017

Competing Interests: The authors have declared that no competing interests exist.

  • Conceptualization: EG-P.

  • Data curation: RV-B LR-O YA.

  • Formal analysis: RV-B IM.

  • Funding acquisition: EG-P.

  • Investigation: RV-B LR-O YA MR CP.

  • Project administration: RV-B AO EG-P.

  • Resources: RV-B MR CP IM EG-P.

  • Supervision: RV-B EG-P.

  • Validation: IM CG-I.

  • Visualization: RV-B AO EG-P.

  • Writing: original draft: RV-B AO EG-P.

  • Writing: review & editing: RV-B LR-O SM YA MR CP CG-I IM AO JE EG-P.

* E-mail: egparra@fjd.es (EGP); ricardo.villa@fjd.es (RVB).
© 2017 Villa-Bellosta et al2017Villa-Bellosta et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.http://dx.doi.org/10.13039/501100004587Instituto de Salud Carlos IIICD14/00198Villa-Bellosta Ricardo http://dx.doi.org/10.13039/501100003329Ministerio de Economía y CompetitividadSAF-2014-60699-JINVilla-Bellosta Ricardo http://dx.doi.org/10.13039/501100004587Instituto de Salud Carlos IIIFIS PI16/01298González-Parra Emilio http://dx.doi.org/10.13039/501100004587Instituto de Salud Carlos IIIPI13/00047Ortiz Alberto http://dx.doi.org/10.13039/501100004587Instituto de Salud Carlos IIIPI16/02057Ortiz Alberto REDinRENRD12/0021Ortiz Alberto REDinRENRD16/0009Ortiz Alberto FRIATOrtiz Alberto FRIATEgido Jesús This work was supported by FIS PI16/01298, PI13/00047, PI16/02057, FEDER funds ISCIII-RETIC REDinREN RD12/0021, RD16/0009, FRIAT and Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to A.O. The Spanish Ministerio de Economía y Competitividad (SAF-2014-60699-JIN) and Instituto de Salud Carlos III (“Sara borrell” CD14/00198 postdoctoral contract) supports R.V-B.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:45:12.075549+00:00

DOI: 10.1371/journal.pone.0173831 · PMC5365126